Skip to main content
Log in

Lipidtherapie bei Diabetikern — ein Update

Diabetes and lipids — lipids and diabetes

Diabetologie

  • Fortbildung -- Schwerpunkt
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Bei Diabetikern lohnt es sich, auf die Lipide zu schauen. Denn diese Patienten haben schon allein aufgrund der Diabetes-Erkrankung ein erhöhtes kardiovaskuläres Risiko. Wie Sie die individuell passende Lipidtherapie für den einzelnen Patienten finden, erfahren Sie im nachfolgenden Beitrag.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. IDF Diabetes Atlas-ninth edition. https://diabetesatlas.org/en/

  2. Parhofer KG, Birkenfeld AL, Krone W, et al. Position Paper on Lipid Therapy in Patients with Diabetes Mellitus. Experimental and clinical endocrinology & diabetes official journal, German Society of Endocrinology [and] German Diabetes Association 2019;127(S 01):S97–S101.

    CAS  Google Scholar 

  3. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European heart journal 2020;41(1):111–88.

    Article  Google Scholar 

  4. Parhofer KG. The Treatment of Disorders of Lipid Metabolism. Deutsches Arzteblatt international 2016;113(15):261–8.

    PubMed  PubMed Central  Google Scholar 

  5. Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical journal of the American Society of Nephrology CJASN 2017;12(12):2032–45.

    Article  CAS  Google Scholar 

  6. Fellström BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. The New England journal of medicine 2009;360(14):1395–407.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisa Waldmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Waldmann, E. Lipidtherapie bei Diabetikern — ein Update. MMW - Fortschritte der Medizin 162, 38–42 (2020). https://doi.org/10.1007/s15006-020-0427-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-020-0427-6

Keywords

Navigation